Do not miss our webinar series! This month our aim is to provide sickle cell disease providers, warriors, caregivers, and their families with tailored expertise and the opportunity to interact with experts through our live virtual Q&A sessions.
CMEs and Enduring Materials are offered.
The objectives addressed:
- What constitutes racial bias in sickle cell disease treatment?
- What is the impact of racism in the treatment and outcome of sickle cell disease?
- Can healthcare providers assess themselves for implicit bias?
- What constitutes a safe space for people who have sickle cell disease?
Meet our Subject-Matter Expert | Marsha Treadwell, Ph.D.
Marsha Treadwell, Ph.D. is a Professor of Pediatrics at the University of California San Francisco. She received her doctorate in clinical child psychology from the University of Washington in Seattle, Washington, and advanced training in clinical research from UCSF. She leads an internationally recognized program of research focused on populations affected by sickle cell disease and on how social determinants, psychological and behavioral factors, and organizational structures and processes impact their health and well-being.
Meet our Moderator | Keith Quirolo, M.D.
Dr. Quirolo has a degree in biology from San Francisco State University, a degree in nursing from the UCSF School of Nursing, he received his MD degree from Case Western Reserve School of Medicine and completed a Fellowship in Transfusion Medicine at UCSF. Dr. Quirolo practiced as an RN for approximately 10 years in pediatric oncology and intensive care in the Bay Area and during medical school at Rainbow Baby and Children’s Hospital in Cleveland Ohio. After his pediatric residency, he entered private pediatric practice in Berkeley for about 10 years. He moved to the sickle cell program at the then-Children’s Hospital Oakland in 1995. He served as the Director of Pediatric Sickle Cell Program at UCSF Benioff Children’s Hospital in Oakland for 20 years. Keith served on the FDA Blood Advisory Committee for two years, and he initiated and directed the Clinical Apheresis Program at UCSF Benioff Children’s Hospital for 17 years. Keith has left the practice of medicine and is currently consulting for community-based organizations and other advocacy projects.